New Orleans, LA – December 8, 2024 – PharmID, a leader in advanced pharmacy solutions, proudly announces the launch of its next-generation WasteWitness System at the ASHP 2024 Midyear Clinical Meeting. Purpose-built for point-of-care areas, including high-risk procedural environments such as operating rooms, this innovative system transforms controlled substance waste management by integrating seamlessly into medication management workflows to ensure chain of custody and enhance compliance.

“With WasteWitness, we’re addressing a critical gap in healthcare,” said James DePoy, CEO of PharmID. “This system is designed to simplify waste management at the point of care, ensuring accuracy and compliance without disrupting existing workflows. It’s a solution that aligns with the fast-paced demands of procedural areas while providing unmatched accountability.”

The WasteWitness System empowers healthcare providers with real-time waste verification, reducing errors and streamlining workflows. By combining state-of-the-art hardware with a cloud-based software solution, it supports a closed-loop medication process that promotes accuracy, accountability, and efficiency.

Visit PharmID at Booth #1853 during ASHP 2024 to experience the WasteWitness System firsthand and learn more about transforming your medication waste management.

About PharmID

PharmID, headquartered in Kirkland, WA, is a pioneering provider of advanced solutions for controlled substance management. Focused on improving safety, compliance, and efficiency, PharmID’s technologies, including the WasteWitness® system, support hospitals and healthcare organizations in preventing diversion and safeguarding patient safety. For more information, visit pharmid.com.

Contact:

Robb Young | Head of Partnerships | robby@pharmid.com